There seems to be something stirring deep in the bowels of MYX. The E4 announcement by Mithra may have been the catalyst as it was certainly informative and helped give a greater understanding of the environmental benefits of E4.
So my question is: is the potential of E4, a 2021 story and the pending Nuvaring FDA approval enough to start to move the Mayne Pharma share price upwards significantly?
Thoughts?
MYX
mayne pharma group limited
Add to My Watchlist
0.00%
!
$5.00

Chart - MYX, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.00 |
Change
0.000(0.00%) |
Mkt cap ! $406.2M |
Open | High | Low | Value | Volume |
$4.99 | $5.07 | $4.96 | $1.626M | 325.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2153 | $4.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.00 | 7764 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2153 | 4.990 |
2 | 9665 | 4.970 |
1 | 201 | 4.960 |
1 | 125 | 4.950 |
1 | 218 | 4.940 |
Price($) | Vol. | No. |
---|---|---|
5.040 | 762 | 1 |
5.050 | 762 | 1 |
5.060 | 5000 | 1 |
5.070 | 762 | 1 |
5.080 | 762 | 1 |
Last trade - 16.12pm 01/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Dr. Hartley Atkinson, MD
Dr. Hartley Atkinson
MD
Previous Video
Next Video
SPONSORED BY The Market Online